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Background
Recently published issues on asthma phenotyping topic are
trying to focus our attention on the geterogensity of asthma
in general. By presenting our two cases we would like put a
stress on the variety features inside the group of patients
with asthma associated with obesity or overweight. This
study describes two clinical cases with uncontrolled asthma.
Both patients received inhaled therapy with fixed combina-
tion IGCS / LABA (1000 mg by fluticasone / salmeterol).
Method
Clinical case 1: male,27 year-old, with early start of
asthma- at the age of 6. The main complaints were short-
ness of breath, predominantly daytime symptoms, the
requirement of rescue medication despite the control
medication 4-5 times a week; history of 1 exacerbation in
the past year. Comorbidities: Allergic rhinitis under con-
trol. BMI 31.4%, ACQ 2.43. According to blood count -
neutrophils 72.7%, absolute value 7.8x10^9, eosinophils
0.032. FEV1 57.6%. Sputum analysis – less than 3 neutro-
phils, 4 eos.
Clinical case 2: female,57 year-old, late asthma onset at
age of 48 during the menopause period. The main com-
plaints were cough, night symptoms, shortness of breath
on exertion, daily use of rescue medication. No atopic
anamnesis; history of 2 exacerbation in the current year.
BMI 22%, WC 91 cm. According to blood count - neu-
trophils 65.6%, absolute value 5.5x10^9, eosinophils 1.6%,
absolute value 0.013. Sputum analysis – 4 neutrophils,
2 eos. FEV1 64%.
The period of supervision was 12 month for both
cases.
Results
Type of therapy: Clinical case1: lifestyle and behavior cor-
rection. Pharmacotherapy was not changed. Outcome:
controlled asthma due to clinical and functional para-
meters in parallel BMI reduction- BMI 26.6% (BMI initial
increase on the first controlled time point could be the
result of redistribution of fat and muscle tissue’s mass.
Clinical case 2: Type of therapy IGCS dosage was not
escalated, additional control medication was prescribed
(antileukotrienes) Outcome partly controlled. Positive
inflammation status observed in both cases.
Conclusion
The asthma control level assessment should be complex
and include inflammation parameters, weight status
(BMI, WC) in oder to develop individual schemes in
therapy algorithm in overweight patients.
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